201 related articles for article (PubMed ID: 11882441)
21. Seven-year follow-up after dobutamine stress echocardiography: impact of gender on prognosis.
Biagini E; Elhendy A; Bax JJ; Rizzello V; Schinkel AF; van Domburg RT; Kertai MD; Krenning BJ; Bountioukos M; Rapezzi C; Branzi A; Simoons ML; Poldermans D
J Am Coll Cardiol; 2005 Jan; 45(1):93-7. PubMed ID: 15629381
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of peak and post-exercise treadmill exercise echocardiography in patients with known or suspected coronary artery disease.
Peteiro J; Bouzas-Mosquera A; Broullón FJ; Garcia-Campos A; Pazos P; Castro-Beiras A
Eur Heart J; 2010 Jan; 31(2):187-95. PubMed ID: 19825812
[TBL] [Abstract][Full Text] [Related]
23. Vasodilator stress echocardiography for risk stratification of medically stabilized unstable angina.
Gigli G; Cortigiani L; Vallebona A; Orlandi S; Mariani PR; Volterrani C
Eur J Echocardiogr; 2002 Mar; 3(1):59-66. PubMed ID: 12067536
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of pharmacologic stress echocardiography in patients with left bundle branch block.
Cortigiani L; Picano E; Vigna C; Lattanzi F; Coletta C; Mariotti E; Bigi R;
Am J Med; 2001 Apr; 110(5):361-9. PubMed ID: 11286950
[TBL] [Abstract][Full Text] [Related]
25. Risk stratification by pharmacological stress echocardiography in a primary care cardiology centre. Experience in 1082 patients.
Cortigiani L; Lombardi M; Landi P; Paolini EA; Nannini E
Eur Heart J; 1998 Nov; 19(11):1673-80. PubMed ID: 9857920
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups.
Pingitore A; Picano E; Varga A; Gigli G; Cortigiani L; Previtali M; Minardi G; Colosso MQ; Lowenstein J; Mathias W; Landi P
J Am Coll Cardiol; 1999 Nov; 34(6):1769-77. PubMed ID: 10577568
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implication of stress echocardiography in 6214 hypertensive and 5328 normotensive patients.
Cortigiani L; Bigi R; Landi P; Bovenzi F; Picano E; Sicari R
Eur Heart J; 2011 Jun; 32(12):1509-18. PubMed ID: 21411815
[TBL] [Abstract][Full Text] [Related]
28. Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography.
Biagini E; Schinkel AF; Bax JJ; Rizzello V; van Domburg RT; Krenning BJ; Bountioukos M; Pedone C; Vourvouri EC; Rapezzi C; Branzi A; Roelandt JR; Poldermans D
Heart; 2005 Jun; 91(6):737-42. PubMed ID: 15894765
[TBL] [Abstract][Full Text] [Related]
29. Dual imaging stress echocardiography versus computed tomography coronary angiography for risk stratification of patients with chest pain of unknown origin.
Ciampi Q; Rigo F; Grolla E; Picano E; Cortigiani L
Cardiovasc Ultrasound; 2015 Apr; 13():21. PubMed ID: 25896850
[TBL] [Abstract][Full Text] [Related]
30. Dobutamine stress echocardiography and the effect of revascularization on outcome in diabetic and non-diabetic patients with chronic ischaemic left ventricular dysfunction.
Cortigiani L; Sicari R; Desideri A; Bigi R; Bovenzi F; Picano E;
Eur J Heart Fail; 2007 Oct; 9(10):1038-43. PubMed ID: 17707132
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease.
Cortigiani L; Dodi C; Paolini EA; Bernardi D; Bruno G; Nannini E
J Am Coll Cardiol; 1998 Dec; 32(7):1975-81. PubMed ID: 9857881
[TBL] [Abstract][Full Text] [Related]
32. Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation.
Rizzello V; Poldermans D; Schinkel AF; Biagini E; Boersma E; Elhendy A; Sozzi FB; Maat A; Crea F; Roelandt JR; Bax JJ
Heart; 2006 Feb; 92(2):239-44. PubMed ID: 15814593
[TBL] [Abstract][Full Text] [Related]
33. Prognostic implication of appropriateness criteria for pharmacologic stress echocardiography performed in an outpatient clinic [corrected].
Cortigiani L; Bigi R; Bovenzi F; Molinaro S; Picano E; Sicari R
Circ Cardiovasc Imaging; 2012 May; 5(3):298-305. PubMed ID: 22467675
[TBL] [Abstract][Full Text] [Related]
34. Independent and incremental value of stress echocardiography over clinical and stress electrocardiographic parameters for the prediction of hard cardiac events in new-onset suspected angina with no history of coronary artery disease.
Chelliah R; Anantharam B; Burden L; Alhajiri A; Senior R
Eur J Echocardiogr; 2010 Dec; 11(10):875-82. PubMed ID: 20667847
[TBL] [Abstract][Full Text] [Related]
35. The difference between acute coronary heart disease and ischaemic stroke risk with regard to gender and age in Finnish and Swedish populations.
Hyvärinen M; Qiao Q; Tuomilehto J; Söderberg S; Eliasson M; Stehouwer CD
Int J Stroke; 2010 Jun; 5(3):152-6. PubMed ID: 20536610
[TBL] [Abstract][Full Text] [Related]
36. The clinical efficacy and long-term prognostic value of stress echocardiography in octogenarians.
Gurunathan S; Ahmed A; Pabla J; Karogiannis N; Hua A; Young G; Nalin Shah B; Senior R
Heart; 2017 Apr; 103(7):517-523. PubMed ID: 27694111
[TBL] [Abstract][Full Text] [Related]
37. Role of contrast-enhanced dobutamine stress echocardiography in predicting outcome in patients with known or suspected coronary artery disease.
Wake R; Takeuchi M; Yoshitani H; Miyazaki C; Otani S; Yoshiyama M; Yoshikawa J
Echocardiography; 2006 Sep; 23(8):642-9. PubMed ID: 16970715
[TBL] [Abstract][Full Text] [Related]
38. The additive prognostic value of wall motion abnormalities and coronary flow reserve during dipyridamole stress echo.
Rigo F; Sicari R; Gherardi S; Djordjevic-Dikic A; Cortigiani L; Picano E
Eur Heart J; 2008 Jan; 29(1):79-88. PubMed ID: 18063595
[TBL] [Abstract][Full Text] [Related]
39. Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis.
Martínez-Sellés M; Doughty RN; Poppe K; Whalley GA; Earle N; Tribouilloy C; McMurray JJ; Swedberg K; Køber L; Berry C; Squire I;
Eur J Heart Fail; 2012 May; 14(5):473-9. PubMed ID: 22402958
[TBL] [Abstract][Full Text] [Related]
40. Young women with PAD are at high risk of cardiovascular complications.
Wisman PP; Tangelder MJ; van Hattum ES; de Borst GJ; Moll FL
Eur J Vasc Endovasc Surg; 2012 Apr; 43(4):441-5. PubMed ID: 22289611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
